Mark Slevin
- Neurology top 1%
- Neuroinflammation and Neurodegeneration Mechanisms 20
- Cell Biology top 1%
- Biological Psychiatry top 5%
- Developmental Neuroscience top 5%
- Oncology top 2%
-
- Angiogenesis and VEGF in Cancer 35
-
- Protease and Inhibitor Mechanisms 18
-
- Adipokines, Inflammation, and Metabolic Diseases 18
- Acute Ischemic Stroke Management 14
-
- Cell Adhesion Molecules Research 12
-
- Atherosclerosis and Cardiovascular Diseases 11
-
- Alzheimer's disease research and treatments 11
Mark Slevin
214 papers receiving 7.1k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Neurology 827
- Cell Biology 803
- Biological Psychiatry 105
- Developmental Neuroscience 168
- Oncology 1.0k
Countries citing papers authored by Mark Slevin
This map shows the geographic impact of Mark Slevin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Slevin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Slevin more than expected).
Fields of papers citing papers by Mark Slevin
This network shows the impact of papers produced by Mark Slevin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Slevin. The network helps show where Mark Slevin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Slevin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 2 | |
| 6 | 2025 | 2 | |
| 7 | 2025 | 2 | |
| 8 | 2025 | 2 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 34 | |
| 11 | 2023 | 3 | |
| 12 | 2020 | 6 | |
| 13 | 2018 | 17 | |
| 14 | 2017 | 95 | |
| 15 | 2016 | 30 | |
| 16 | 2009 | 20 | |
| 17 | 2009 | 89 | |
| 18 | 2006 | 45 | |
| 19 | 1993 | 33 | |
| 20 | 1986 | 1 |
About Mark Slevin
Mark Slevin is a scholar working on Neurology, Cancer Research and Biological Psychiatry, having authored 223 papers that have together received 7.3k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (35 papers), Neuroinflammation and Neurodegeneration Mechanisms (20 papers), Protease and Inhibitor Mechanisms (18 papers), Adipokines, Inflammation, and Metabolic Diseases (18 papers), Acute Ischemic Stroke Management (14 papers), Cell Adhesion Molecules Research (12 papers), Atherosclerosis and Cardiovascular Diseases (11 papers) and Alzheimer's disease research and treatments (11 papers). The work is most often cited by research in Neurology (827 citations), Cell Biology (803 citations) and Biological Psychiatry (105 citations). Mark Slevin has collaborated with scholars based in United Kingdom, Spain and Romania. Frequent co-authors include Jerzy Krupiński, John Gaffney, Shant Kumar, Lina Badimón, Nessar Ahmed, Pat Kumar, Sabine Matou, S. Kumar, Patricia Kumar and Esther Peña. Their work appears in journals such as British Journal of Cancer, International Journal of Molecular Sciences, Frontiers in Immunology, Scientific Reports and Stroke.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.